229 Impact of cystic fibrosis transmembrane conductance regulator modulator therapy on nutritional status, hepatic steatosis, and dyslipidemia
| Autor: | Sundaram, K., McBennett, K., Flask, C., Kutney, K. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis October 2022 21 Supplement 2:S136-S136 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect